KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) Other Non Operating Income (2017 - 2025)

Guardant Health (GH) has disclosed Other Non Operating Income for 9 consecutive years, with -$18.3 million as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income fell 491.43% to -$18.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$10.5 million through Dec 2025, up 75.38% year-over-year, with the annual reading at -$10.5 million for FY2025, 75.38% up from the prior year.
  • Other Non Operating Income hit -$18.3 million in Q4 2025 for Guardant Health, down from -$48000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $41.3 million in Q2 2023 to a low of -$29.1 million in Q1 2024.
  • Historically, Other Non Operating Income has averaged $35058.8 across 5 years, with a median of -$48000.0 in 2022.
  • Biggest YoY gain for Other Non Operating Income was 10815.08% in 2023; the steepest drop was 3345.83% in 2023.
  • Year by year, Other Non Operating Income stood at $720000.0 in 2021, then tumbled by 47.5% to $378000.0 in 2022, then crashed by 977.25% to -$3.3 million in 2023, then skyrocketed by 240.74% to $4.7 million in 2024, then plummeted by 491.43% to -$18.3 million in 2025.
  • Business Quant data shows Other Non Operating Income for GH at -$18.3 million in Q4 2025, -$48000.0 in Q3 2025, and -$25000.0 in Q2 2025.